Optiver Holding
GYRE icon

Optiver Holding’s Gyre Therapeutics GYRE Stock Holding History

Optiver Holding’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40 Sell
6
-96
-94% -$654 ﹤0.01% 2680
2026
Q1 		$711 Sell
102
-120
-54% -$932 ﹤0.01% 2112
2025
Q4 		$1.57K Hold
222
– – ﹤0.01% 2115
2025
Q3 		$1.66K Buy
+222
New +$1.69K ﹤0.01% 2428

Other funds holding GYRE

HH
HSG Holding Na, Hong Kong $1.2B AUM 23.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Optiver Holding's GYRE Position: Q2 2026 in Review

Optiver Holding reduced its Gyre Therapeutics (GYRE) stake by 94% in Q2 2026, selling an estimated $654 and leaving 6 shares worth $40. The position accounts for ﹤0.01% of the portfolio, ranked #2680.

Optiver Holding first reported a position in GYRE in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.66K in Q3 2025. 60 funds tracked by Wall St. Rank hold GYRE as of Q2 2026.

  • Optiver Holding held 6 shares of Gyre Therapeutics worth $40 as of Q2 2026.
  • Optiver Holding sold 96 Gyre Therapeutics shares in Q2 2026, an estimated $654.
  • Gyre Therapeutics made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #2680 holding.
  • Optiver Holding first reported a position in Gyre Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • Optiver Holding's Gyre Therapeutics position peaked at $1.66K in Q3 2025.
  • 60 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.